Yan X, Liu SM, Liu C. Onco Targets Ther. 2022;15:1355–1368
The authors have advised that Xing Yan and Shan Mei Liu should be considered as equally contributed authors for this paper titled “Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect” published in OncoTargets and Therapy on November 10, 2022.
The updated author list should read as follows:
Xing Yan1,* Shan Mei Liu2,*, Changhong Liu1
1The Second Affiliated Hospital of Dalian Medical University, Dalian, 116000, People’s Republic of China; 2Inner Mongolia Medical University, Hohhot, 150110, People’s Republic of China
Correspondence: Changhong Liu, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116000, People’s Republic of China, Tel +86 17709870870, Email [email protected]
*These authors contributed equally to this work
The authors apologize for this oversight.
留言 (0)